quinazolines has been researched along with Sarcoma, Ewing in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo Vieira, I; Brufatto Olguins, D; Brunetto de Farias, C; José Gregianin, L; Kersting, N; Kunzler Souza, B; Lunardi Brunetto, A; Pereira Dos Santos, R; Roesler, R; Schwartsmann, G; Tesainer Brunetto, A | 1 |
| Alexe, G; Berman, JN; Boxer, MB; Conway Saur, A; Crompton, BD; Davis, MI; Guha, R; Hall, MD; Hughes, E; Hwang, EE; Kung, A; Lemieux, ME; McKnight, C; Melong, N; O'Neill, AF; Shen, M; Stegmaier, K; Veinotte, CJ; Wang, A; Wang, S; Wuerthele, K; Xu, X | 1 |
| Billups, CA; Carol, H; Gorlick, R; Houghton, PJ; Keir, ST; Kolb, EA; Lock, R; Maris, JM; Morton, CL; Reynolds, CP; Smith, MA | 1 |
| Badinloo, M; Hajializadeh, Z; Jangi-Aghdam, H; Pooraboli, I; Rajabalian, S | 1 |
| Berglund, C; Chernoguz, A; Crawford, K; Cripe, TP; Donovan, E; Frischer, JS; Vandersall, A | 1 |
5 other study(ies) available for quinazolines and Sarcoma, Ewing
| Article | Year |
|---|---|
Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell Function.
Topics: Bone Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Humans; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinazolines; Sarcoma, Ewing; Signal Transduction; Tumor Suppressor Protein p53; Tyrphostins | 2018 |
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
Topics: Aminopyridines; Animals; Apoptosis; Aurora Kinase B; Bone Neoplasms; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Female; Focal Adhesion Kinase 1; High-Throughput Screening Assays; Humans; Indoles; Mice; Mice, Nude; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Sarcoma, Ewing; Small Molecule Libraries; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zebrafish | 2019 |
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Topics: Animals; Antimitotic Agents; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Female; Glioblastoma; Humans; Injections, Intraperitoneal; Kinesins; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Osteosarcoma; Quinazolines; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Single-Blind Method; Spindle Apparatus; Tumor Stem Cell Assay; Wilms Tumor; Xenograft Model Antitumor Assays | 2009 |
Establishment, characterization, and drug sensitivity of a new Ewing sarcoma cell line (SS-ES-1).
Topics: Adolescent; Antineoplastic Agents; Biomarkers, Tumor; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Female; Humans; Neoplasm Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Quinazolines; RNA-Binding Protein EWS; Sarcoma, Ewing; Soft Tissue Neoplasms; Tamoxifen; Tyrphostins | 2010 |
EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
Topics: Angiography; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; ErbB Receptors; Female; Gefitinib; Humans; In Vitro Techniques; Mice; Mice, Nude; Neovascularization, Pathologic; Quinazolines; Sarcoma, Ewing; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2012 |